TMC, Author at TMC - Page 4 of 9

Services
TMC is a global pharma services company that delivers drug development solutions across the full product lifecycle — from early-phase clinical development to market access and drug commercialisation.

Our integrated pharma services and end-to-end support enable small to mid-sized biotech and pharma companies to retain control, maximise value and bring transformative therapies to patients faster.
Consulting
Clinical
Commercial
About Us
TMC is a global pharma services company supporting small to mid-sized biotech and pharma companies worldwide — across all stages of drug development.

Our experienced, senior specialists help you navigate clinical and regulatory complexity, accelerate drug development timelines and bring life-changing therapies to patients faster through expert, end-to-end support across clinical development, functional execution and drug commercialisation.
Our Leadership Team
Our Associates
Our ESG
Testimonials
Resources
News & Events
- News
- Events
Careers with TMC
- Join Our Team
- Join Our Network
Contact Us

About TMC

This author has not yet filled in any details.
So far TMC has created 81 blog entries.

Rare Conversations podcast: Data collection & integrity

By TMC|2025-11-03T15:25:02+00:008 August 2025|Podcast|0 Comments

Rare Conversations podcast: Regulatory fragmentation across countries

By TMC|2025-11-03T15:30:00+00:008 August 2025|Podcast|0 Comments

Rare Conversations podcast: Four key considerations

By TMC|2025-11-03T15:25:36+00:008 August 2025|Podcast|0 Comments

Rare Conversations podcast: Patient population & challenges

By TMC|2025-11-03T15:26:29+00:008 August 2025|Podcast|0 Comments

Rare Conversations podcast: Can fully decentralised clinical trials work in the rare disease landscape?

By TMC|2025-11-03T15:32:42+00:005 August 2025|Podcast|0 Comments

Your essential checklist for an effective regulatory submission

Bringing a new drug to market is a complex, [...]

By TMC|2025-10-22T17:51:02+01:0026 June 2025|Blog|0 Comments

10 common pharmacovigilance inspection findings and their implications

Pharmacovigilance (PV) plays a crucial role in assuring patient [...]

By TMC|2025-10-22T17:56:16+01:0026 June 2025|Blog|0 Comments

Taking an inquirer-centric approach to rare disease medical information

By Marcelo Vaz, Vice President of Medical Services at [...]

By TMC|2025-08-21T11:57:28+01:0025 June 2025|In the media|0 Comments

Windsor Framework update

By TMC|2025-11-03T15:37:16+00:009 June 2025|Talking Head Videos|0 Comments

The importance of incorporating decentralised clinical trials (DCTS) and patient centricity by design in rare disease studies

By Marcelo Vaz, Vice President of Medical Services at [...]

By TMC|2025-08-21T12:00:04+01:0027 May 2025|In the media|0 Comments

Previous 345 Next